METTL3 Promotes Osteosarcoma Malignancy by Silencing SFRP1 in Lab Models
Researchers found that METTL3-mediated m6A modification of UHRF1 promotes osteosarcoma malignancy by silencing the tumor suppressor SFRP1 through promoter DNA ...
Researchers found that METTL3-mediated m6A modification of UHRF1 promotes osteosarcoma malignancy by silencing the tumor suppressor SFRP1 through promoter DNA ...
Esketamine improved cognitive performance and suppressed neuronal apoptosis in perioperative neurocognitive disorder models by stabilizing DHCR24 expression through METTL3-mediated m6A ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.